ARTG 407849Multiple-viruses IVDs
ARTG ID: 407849 · Emergence Technology Pty Ltd · Assure Tech (Hangzhou) Co Ltd · Class IIb · Started April 18, 2023
Good Name: Emergence Technology Pty Ltd - Multiple-viruses IVDs
- Risk Class
- Class IIb
- Product Type
- IVD
- ARTG Category
- IVD
- ARTG ID
- 407849
- Start Date
- April 18, 2023
- Effective Date
- September 11, 2024
- Country
- China
- Address
- Building 4 No 1418-50 Moganshan Road Gongshu District, Hangzhou, Zhejiang, 310011
This COVID19 Influenza A/B Antigen Nasal Test Kit is an in vitro immunoassay. The assay is for the direct and qualitative detection of viral nucleocapsid proteins of SARS CoV 2, Influenza A virus, and Influenza B virus from nasal secretions.
Access comprehensive regulatory information for Multiple-viruses IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 407849 and sponsored by Emergence Technology Pty Ltd, manufactured by Assure Tech (Hangzhou) Co Ltd in China. The device registration started on April 18, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.